BioStem Technologies (BSEM) Earnings Date, Estimates & Call Transcripts 10.04 +0.28 (+2.82%) (As of 09/19/2024 09:05 PM ET) Add Compare Share Share Earnings Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Earnings SummaryLatest Earnings DateAug. 12EstimatedActual EPS (Aug. 12) 0.30 Beat By 0.18 Consensus EPS (Aug. 12) 0.12 Conference Call TranscriptConference Call Audio Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueBSEM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BSEM Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Behind the MarketsImminent FDA Decision Could End Obesity in America...This drug could end obesity in America... ...and spark a 224,000% sales surge for one tiny micro-cap stock. Channelnomics says it "Could have a greater impact on the world than artificial intelligence."Get the name of this stock here >>> BioStem Technologies Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 202410.740.740.74Q2 202410.770.770.77Q3 202410.800.800.80Q4 202410.830.830.83FY 202443.143.143.14Q1 202510.790.790.79Q2 202510.800.800.80Q3 202510.800.800.80Q4 202510.810.810.81FY 202543.203.203.20BSEM Earnings Date and InformationBioStem Technologies last posted its quarterly earnings data on August 12th, 2024. The reported 0.30 earnings per share for the quarter, beating the consensus estimate of 0.12 by 0.18. The business had revenue of 74.49 million for the quarter, compared to analyst estimates of 43.99 million. BioStem Technologies has generated 0.00 earnings per share over the last year and currently has a price-to-earnings ratio of 25.3. Earnings for BioStem Technologies are expected to grow by 34.51% in the coming year, from 1.13 to 1.52 per share. Read More BioStem Technologies Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks8/12/2024Q2 20240.120.30+0.180.3043.99 million74.49 million 5/14/2024Q1 20240.740.20-0.540.2012.70 million41.90 million4/1/2024Q4 2023--0.14-0.14-0.1411.40 million11.44 million11/13/2023Q3 2023-0.180.03+0.210.031.39 million3.60 million BioStem Technologies Earnings - Frequently Asked Questions When did BioStem Technologies announce their last quarterly earnings? BioStem Technologies (OTCMKTS:BSEM) last announced its quarterly earning data on Monday, August 12, 2024. Learn more on BSEM's earnings history. Did BioStem Technologies beat their earnings estimates last quarter? In the previous quarter, BioStem Technologies (OTCMKTS:BSEM) reported 0.30 earnings per share (EPS) to beat the analysts' consensus estimate of 0.12 by 0.18. Learn more on analysts' earnings estimate vs. BSEM's actual earnings. How can I listen to BioStem Technologies's earnings conference call? The conference call for BioStem Technologies's latest earnings report can be listened to online. Listen to Conference Call How can I read BioStem Technologies's conference call transcript? The conference call transcript for BioStem Technologies's latest earnings report can be read online. Read Transcript How much revenue does BioStem Technologies generate each year? BioStem Technologies (OTCMKTS:BSEM) has a recorded annual revenue of $16.68 million. What is BioStem Technologies's price-to-earnings ratio? BioStem Technologies (OTCMKTS:BSEM) has a trailing price-to-earnings ratio of 25.26 and a forward price-to-earnings ratio of 8.88. What is BioStem Technologies's EPS forecast for next year? BioStem Technologies's earnings are expected to grow from 1.13 per share to 1.52 per share in the next year, which is a 34.51% increase. More Earnings Resources from MarketBeat Related Companies: Paragon 28 Earnings Results SI-BONE Earnings Results Exscientia Earnings Results Orthofix Medical Earnings Results Pacira BioSciences Earnings Results IGM Biosciences Earnings Results Terns Pharmaceuticals Earnings Results Mineralys Therapeutics Earnings Results Y-mAbs Therapeutics Earnings Results Annexon Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GameStop: Earnings Won’t Save It, Dilution Points to TroubleIs Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 Earnings This page (OTCMKTS:BSEM) was last updated on 9/20/2024 by MarketBeat.com Staff From Our PartnersBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredNew President Kamala warningFinancial nightmare coming after election In 2018, one independent research predicted Kamala Harris was on ...Stansberry Research | SponsoredBiden's Executive Order, Dems Digital Money Legislation, First Step ToDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans...Monetary Gold | SponsoredAct by Friday, August 16th, to collect this 22% dividendLet's do a little math here... To double your money at a 3% rate of return, you would need around 23 years....Investors Alley | SponsoredThis Crypto Is Set to Explode in SeptemberWith thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make ...Crypto 101 Media | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredNew September Stock WarningSeptember is the most volatile month of the year for stocks. And after the brutal tech selloff, one Wall St...Chaikin Analytics | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding BioStem Technologies, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share BioStem Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
